Researchers at the University of Iowa Holden Comprehensive Cancer Center (UIHC) in the United States have received a $9.7 million five-year grant from the U.S. National Cancer Institute to study how high doses of vitamin C may help treat various forms of cancer.
With awareness growing regarding the beneficial role of vitamin C in the treatment of cancer, the blatantly false claims that the pharmaceutical and medical status quo has been making about chemotherapy and radiation treatments are no longer credible. Realizing that a cancer-free world is possible, patients are increasingly therefore demanding access to safe and effective natural health approaches.
In these latest studies, the UIHC researchers say they are planning to study high-dose intravenous vitamin C in the treatment of three of the deadliest cancers affecting the U.S. population: pancreatic cancer; non-small cell lung cancer; and glioblastoma, an aggressive type of brain cancer.
As useful as intravenous vitamin C is in the treatment of cancer, however, research conducted at under the direction of Dr. Aleksandra Niedzwiecki at the Dr. Rath Research Institute has already shown how carefully designed supplements containing combinations of micronutrients can bring results that are far superior to those from any single micronutrient used alone. Significantly, these combinations have been found effective not just in pancreatic cancer, lung cancer and brain tumors, but in ALL human cancer cell lines tested.
To learn more about the Dr. Rath Research Institute’s breakthrough cancer studies, download free copies of the chapters from Victory Over Cancer, the life saving book by authored by Dr. Rath and Dr.Niedzwiecki.
Read article at dailyiowan.com (United States)
University Of Iowa Cancer Center Receives $9.7 Million Grant To Study Vitamin C As Cancer Treatment
- Category: Health
- Hits: 993